Egerton Capital (UK) LLP: CME position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Egerton Capital (UK) LLP on CME, newest first. How the timeline and the estimate are built.
Egerton Capital (UK) LLP held 0 CME shares at 2026-06-30 per its 13F-HR filed 2026-07-21.
the latest 13F is the newest step
- period ended2026-06-3013F 0 sharesChange vs previous 13F -1,182,907 shares
13F-HR 0001581811-26-000007 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2026-03-3113F 1,182,907 sharesChange vs previous 13F +3,115 shares
3.88% of the 13F portfolio, value $349,371,582.
13F-HR 0001581811-26-000005 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,179,792 sharesChange vs previous 13F -4,996 shares
3.5% of the 13F portfolio, value $322,177,599.
13F-HR 0001581811-26-000002 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,184,788 sharesChange vs previous 13F -338,148 shares
3.38% of the 13F portfolio, value $320,117,870.
13F-HR 0001581811-25-000010 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,522,936 sharesChange vs previous 13F -207,258 shares
4.31% of the 13F portfolio, value $419,751,620.
13F-HR 0001581811-25-000007 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,730,194 sharesChange vs previous 13F +765,773 shares
5.3% of the 13F portfolio, value $459,003,166.
13F-HR 0001581811-25-000005 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 964,421 sharesChange vs previous 13F not available
2.59% of the 13F portfolio, value $223,967,489.
13F-HR 0001581811-25-000004 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).